Table 2. Development of nephrolithiasis by non-alcoholic fatty liver disease (NAFLD).
Presence of NAFLD | Person-year | Incident case | Incidence density (per 100 person-years) | Aged-adjusted HR (95% CI) | Multivariate HRa (95% CI) | |
---|---|---|---|---|---|---|
Model 1 | Model 2 | |||||
Men | ||||||
No NAFLD | 459,878.1 | 6,061 | 1.3 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
NAFLD | 595,009.5 | 4,462 | 1.8 | 1.32 (1.27–1.37) | 1.16 (1.11–1.22) | 1.17 (1.06–1.30) |
Women | ||||||
No NAFLD | 417,820.6 | 5,198 | 1.2 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
NAFLD | 42,057.6 | 721 | 1.7 | 1.10 (1.01–1.19) | 1.07 (0.97–1.17) | 0.97 (0.81–1.16) |
aEstimated from parametric Cox models. Multivariable model 1 was adjusted for age, center, year of screening exam, smoking status, alcohol intake, physical activity, education level, BMI, and history of hypertension and diabetes: Model 2: model 1 plus adjustment for HOMA-IR, uric acid, and hsCRP
BMI, body mass index; CI, confidence intervals; HR, hazard ratios.
p value <0.001 for the interaction between sex and NAFLD for the development of nephrolithiasis.